Parian Global Management LP Oncocyte Corp Transaction History

Parian Global Management LP

  • $30.8 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.53 - $5.89 $3.69 Million - $6.16 Million
-1,045,968 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$3.77 - $6.0 $1.32 Million - $2.1 Million
349,603 Added 50.2%
1,045,968 $6 Million
Q1 2021

May 17, 2021
BUY
$2.39 - $6.5 $1.66 Million - $4.53 Million
696,365 New
696,365 $3.61 Million

Others Institutions Holding OCX

# of Institutions
4
Shares Held
1.5M
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $342M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Parian Global Management LP Portfolio

Follow Parian Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Parian Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email